Jeanne Erdmann is an award-winning health and science writer based in Wentzville, Mo. A member of Association of
Health Care Journalists board of directors, she is the chair of the organization’s Freelance Committee. Her work has appeared in Discover, Women’s Health, Aeon, Slate, The Washington Post, Nature, Nature Medicine and other publications. You can follow her at @jeanne_erdmann.
Jeanne Erdmann
From this contributor
Analysis pins down prevalence of mental health conditions in autism
Eight mental health conditions occur unusually often in autistic people, a new analysis suggests.
Analysis pins down prevalence of mental health conditions in autism
By
Jeanne Erdmann
7 October 2019 | 2 min read
Drug screen reveals potential treatments for Rett syndrome
An experimental leukemia drug and a chemical in black pepper ease breathing and movement problems in a mouse model of Rett syndrome.
Drug screen reveals potential treatments for Rett syndrome
By
Jeanne Erdmann
11 September 2019 | 4 min read
Explore more from The Transmitter
Frameshift: How Caitlin Vander Weele made science communication her business
Her favorite part of research was talking about it. So she left academia and turned that passion into a successful company.
Frameshift: How Caitlin Vander Weele made science communication her business
Her favorite part of research was talking about it. So she left academia and turned that passion into a successful company.
By
Katie Moisse
19 March 2026 | 6 min read
Signs of aging vary across brain cells
Senescence presents differently depending on the cell type, toxic trigger and neighboring cells, two new studies find.
Signs of aging vary across brain cells
Senescence presents differently depending on the cell type, toxic trigger and neighboring cells, two new studies find.
By
Claudia López Lloreda
18 March 2026 | 4 min read
Neuroscientists challenge NIH’s proposed human-data access policy
The changes would restrict the sharing of human neuroimaging, transcriptomic and genetic data.
Neuroscientists challenge NIH’s proposed human-data access policy
The changes would restrict the sharing of human neuroimaging, transcriptomic and genetic data.
By
Claudia López Lloreda
17 March 2026 | 5 min read